preparing vaccine | Care Home Supplier News

Research supports third vaccine dose in clinically vulnerable

Public Health Scotland research has supported a third vaccine dose to people previously on the shielding list and who are known to be clinically extremely vulnerable to COVID-19.

The study, led by Public Health Scotland and supported by the University of Edinburgh, considered whether people classed as clinically extremely vulnerable had the same level of protection from COVID-19 after two doses compared to the rest of the population.

People are designated to be clinically extremely vulnerable to COVID-19 if they have certain medical conditions or take specific medicines that affect their immune system. A weakened immune system not only puts some people at greater risk of experiencing complications with COVID-19, it may also reduce the effectiveness of the vaccines they receive.

Researchers found that people previously in this group had 66 per cent protection against severe COVID-19 disease after two doses of any COVID-19 vaccine compared to 93 per cent protection in those without high-risk conditions.

PHS reports that of the 330 cases of severe COVID-19 in people who were double vaccinated by 2 September 2021, almost half were designated as extremely vulnerable and most of the remainder have been in people with moderate risk conditions.

Discussing the findings, co-author of the study, Professor Helen Colhoun of the University of Edinburgh, said: “The fact that we see an increase in protection from the first to the second dose gives hope that a third dose might increase protection further.”

On 1 September, the Joint Commission on Vaccinations and Immunisations (JCVI) recommended a third dose of vaccine for people who are most immunosuppressed.

Dr Nicholas Phin, Director of Public Health Science at Public Health Scotland, said: “If you are contacted to receive a third dose then please do take the opportunity to bolster your protection against COVID-19.”

Read the full study, ‘Variation in efficacy of COVID-19 vaccination against severe COVID-19 by clinical vulnerability status’ (yet to be peer-reviewed)

Facebooktwitterredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our newsletter
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Decline All
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Decline All
Accept All Cookies
Cookie Settings
STAY UPDATED!
Thank you for visiting CHMonline.co.uk, the website for the leading magazine for care home managers, operators and directors. If you would like to receive the digital edition and/or the editor's regular newsletters via email please subscribe here.
Are you a care home staff member or operator?
Terms: Care Home Management (S&A Publishing) may use the information you provide on this form to get in touch with you with relevant industry news and promotions. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us. We will treat your information with respect. For more information please view our privacy policy.
By submitting this form you agree to the terms.
SUBSCRIBE